Note: If youre already receiving a GLP-1 through Medicare Part D for an FDA-approved covered usesuch as diabetes, cardiovascular disease, MASH, or obstructive sleep apneayoull continue getting that medication through your Part D plan
S.SelvarajS.VeroneseM.RizzoG.BertoldoA.OwenD
Depending on the individual, the answer differs from person to person
Through GLP-1R activation, Orforglipron enhances glucose-dependent insulin secretion, improves glycemic control, contributes to lipid homeostasis, and reduces appetite and food intake, supporting its clinical use in obesity and type 2 diabetes [2]
Although both agents influence body composition and fat metabolism, they do so through entirely distinct biological pathways